IP Verse

Symbiosis Ip Limited Analysis

LAW FIRM ANALYSIS

Latest European patent oppositions filed by Symbiosis Ip Limited

Patent:

Title:

Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer

Applicant:

MERCK SHARP & DOHME CORP.

Opposition Date:

2022-05-26

Patent:

Title:

Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists

Applicant:

MERCK SHARP & DOHME CORP.

Opposition Date:

2021-09-15

Patent Number	Title	Applicant	Opposition Date
EP3498734	Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer	MERCK SHARP & DOHME CORP.	2022-05-26
EP3283882	Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists	MERCK SHARP & DOHME CORP.	2021-09-15

Top clients of Symbiosis Ip Limited filing patent oppositions

Company:

SYMBIOSIS IP LIMITED

Count:

2

Company	Count
SYMBIOSIS IP LIMITED	2